Table 1 Predictors with attributed median weight and corresponding IQR
Patient subgroups | Predictor | Median | IQR |
|---|---|---|---|
Secondary osteoporosis | |||
recent or multiple falls | 9 | 1 | |
aromatase inhibitors | 6.5 | 1 | |
chronic obstructive pulmonary disease | 6.5 | 2 | |
history of transplantation | 6.5 | 2.5 | |
decrease in BMD over the previous 2 years | 6.5 | 2.5 | |
androgen deprivation therapy (prostate cancer) | 6.5 | 2.5 | |
rheumatic diseases other than rheumatoid arthritis (excluded osteoarthritis) | 6.5 | 3 | |
breast cancer therapy | 6 | 1 | |
inflammatory activity of the underlying disease | 6 | 3 | |
severe disability form multiple sclerosis or other neurodegenerative conditions | 6 | 3 | |
Crohn’s disease | 5.5 | 1.5 | |
low grip strength | 5.5 | 1.5 | |
gastric bypass surgery | 5.5 | 2.5 | |
HIV | 5 | 1.5 | |
Primary and secondary osteoporosis | |||
high risk of falls | 9.5 | 1 | |
lumbar spine BMD | 7.5 | 1.5 | |
sarcopenia | 7 | 1.5 | |
dismobility syndrome | 6 | 2 | |
Postmenopausal women | |||
spine fracture status | 10 | 0.5 | |
major height loss | 8 | 3.5 | |
kyphosis | 6.5 | 1.5 | |
early surgical menopause | 6 | 2.5 | |
Nursing home patients | |||
falls | 10 | 1.5 | |
functional status | 8 | 3 | |
Men | |||
spine fracture status | 10 | 0.5 | |
hypogonadism | 4.5 | 3.5 | |
Older adults | |||
falls | 9.5 | 2 | |
functional/ambulatory status | 8.5 | 4.5 | |
medications (particularly psychotropic medications) | 8 | 3 | |
stroke | 6 | 2 | |
type 2 diabetes | 6 | 2 | |
Parkinson’s disease | 6 | 2.5 | |
Close to treatment threshold | |||
lumbar spine BMD (for vertebral fracture prediction) | 8 | 1.5 | |
type 2 diabetes | 6 | 3.5 | |
trabecular bone score (TBS) | 5.5 | 3.5 | |
hip axis length (for hip fracture prediction) | 4 | 4 | |